The limited effect of APOE genotype on sphingolipid levels, even in AD mice, might be due to the fact that the mice in our study were relatively younger (5.4–14.3 months, only 3 mice ≥ 10 months) than in previously published papers. The gene discussed is APOE; the disease is Alzheimer disease.